FDA approves first brain stimulation device for home depression treatment. Flow Neuroscience's FL-100 headset uses electrical stimulation for adults, available in 2026.
Medical Device Network on MSN
Hologic’s Aptima assay secures FDA approval for HPV primary screening
With this FDA approval, Hologic now offers three guideline-recommended methods: Pap testing, HPV primary testing, and ...
The FDA has approved the first prescription, at-home neuromodulation therapy for individuals with major depressive disorder ...
The Implantable Tibial Neuromodulation (ITNM) device will expand treatment options for the 16 million people living with urinary urges and involuntary leaks GALWAY, Ireland, Sept. 19, 2025 /PRNewswire ...
The Gazelle Hb Variant Test has not been cleared or approved by the FDA and is not available for sale in the United States. Breakthrough Device Designation does not guarantee regulatory clearance.
It's not a drug, and it may also have some benefits to quell overeating—here's how tech is transforming mental health care.
The US Food and Drug Administration (FDA) has approved SetPoint Medical’s implantable neuroimmune modulation device, SetPoint System, to treat moderate-to-severe rheumatoid arthritis (RA) in adults.
The FDA approved re-administration of iDose TR for patients with healthy corneas, enhancing treatment flexibility for ...
The Implantable Tibial Neuromodulation (ITNM) device will expand treatment options for the 16 million people living with urinary urges and involuntary leaks Bladder control problems affect an ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results